A
Annemarie M. J. Wensing
Researcher at Utrecht University
Publications - 137
Citations - 7894
Annemarie M. J. Wensing is an academic researcher from Utrecht University. The author has contributed to research in topics: Drug resistance & Population. The author has an hindex of 43, co-authored 119 publications receiving 6977 citations. Previous affiliations of Annemarie M. J. Wensing include University Medical Center Utrecht.
Papers
More filters
Journal ArticleDOI
An automated genotyping system for analysis of HIV-1 and other microbial sequences
Tulio de Oliveira,Koen Deforche,Sharon Cassol,Mika Salminen,D Paraskevis,Christopher J. Seebregts,Joe Snoeck,Estrelita Janse van Rensburg,Annemarie M. J. Wensing,David A. M. C. van de Vijver,Charles A. Boucher,Ricardo Jorge Camacho,Anne-Mieke Vandamme +12 more
TL;DR: The development of an automated genotyping system that can be easily applied to HIV-1 and other rapidly evolving viral pathogens is described.
Journal ArticleDOI
Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
Annemarie M. J. Wensing,David A. M. C. van de Vijver,Gioacchino Angarano,Birgitta Åsjö,Claudia Balotta,Enzo Boeri,Ricardo Jorge Camacho,Maire-Laure Chaix,Dominique Costagliola,Andrea De Luca,Inge Derdelinckx,Zehava Grossman,Osamah Hamouda,Angelos Hatzakis,Robert Hemmer,Andy I. M. Hoepelman,Andrzej Horban,Klaus Korn,Claudia Kücherer,Thomas Leitner,Clive Loveday,E MacRae,I Maljkovic,Carmen de Mendoza,Laurence Meyer,Claus J. Nielsen,Eline L. M. Op de Coul,Vidar Ormaasen,D Paraskevis,Luc Perrin,Elisabeth Puchhammer-Stöckl,Lidia Ruiz,Mika Salminen,Jean-Claude Schmit,François Schneider,Rob Schuurman,Vincent Soriano,G Stanczak,Maja Stanojevic,Anne-Mieke Vandamme,Kristel Van Laethem,Michela Violin,Karin Wilbe,Sabine Yerly,Maurizio Zazzi,Charles A. Boucher +45 more
TL;DR: In this paper, the authors determined the baseline rate of drug resistance in 2208 therapy-naive patients recently and chronically infected with HIV-1 from 19 European countries during 1996-2002.
Journal ArticleDOI
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Ravindra K. Gupta,Sultan Abdul-Jawad,Laura E. McCoy,Hoi Ping Mok,Dimitra Peppa,Maria Salgado,Javier Martinez-Picado,Javier Martinez-Picado,Monique Nijhuis,Annemarie M. J. Wensing,Helen Lee,Paul Grant,Eleni Nastouli,Jonathan Lambert,M Pace,Fanny Salasc,Christopher Monit,Andrew J. Innes,Andrew J. Innes,Luke Muir,Laura Waters,John Frater,Andrew M. L. Lever,Andrew M. L. Lever,Simon Edwards,Ian H Gabriel,Ian H Gabriel,Eduardo Olavarria,Eduardo Olavarria +28 more
TL;DR: It is suggested that a single allogeneic HSCT with homozygous CCR5Δ32 donor cells may be sufficient to achieve HIV-1 remission with reduced intensity conditioning and no irradiation, and the findings provide further support for the development of HIV- 1 remission strategies based on preventing CCR 5 expression.
Journal ArticleDOI
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
TL;DR: This review provides an overview of the history of protease inhibitor therapy, its current status and future perspectives and develops novel PIs with high potency against the known PI-resistant HIV protease variants.
Journal Article
2011 update of the drug resistance mutations in HIV-1.
Victoria A. Johnson,Calvez,Huldrych F. Günthard,Roger Paredes,Deenan Pillay,Robert W. Shafer,Annemarie M. J. Wensing,Douglas D. Richman +7 more
TL;DR: This November 2011 edition of the IAS-USA drug resistance mutations list updates the figures last published in December 2010.